Sequential treatment with lamivudine and alpha-interferon in anti-HBe-positive chronic hepatitis B patients: a pilot study.

Niro, G A; Fontana, R; Gioffreda, D; Fiorella, S; Accadia, L; Iacobellis, A; Caruso, N; Conoscitore, P; Andriulli, A

Niro, G A; Fontana, R; Gioffreda, D; Fiorella, S; Accadia, L; Iacobellis, A; Caruso, N; Conoscitore, P; Andriulli, A.

Affiliation

Niro GA; Division of Gastroenterology, Casa Sollievo Sofferenza Hospital, IRCCS, San Giovanni Rotondo, Italy. g.niro@operapadrepio.it

Dig Liver Dis ; 39(9): 857-63, 2007 Sep.

Article in En | MEDLINE | ID: mdl-17652045

Subject(s)

Antiviral Agents/administration & dosage; Hepatitis B virus/drug effects; Hepatitis B, Chronic/drug therapy; Interferon-alpha/administration & dosage; Lamivudine/administration & dosage; Adult; DNA, Viral/drug effects; Drug Administration Schedule; Drug Resistance, Multiple, Viral/genetics; Female; Hepatitis B virus/genetics; Humans; Interferon alpha-2; Male; Middle Aged; Pilot Projects; Recombinant Proteins; Viral Load

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Antiviral Agents / Hepatitis B virus / Interferon-alpha / Lamivudine / Hepatitis B, Chronic Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Dig Liver Dis Year: 2007 Document type: Article

Search on Google

XML

PubMed Links